Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Valproic Acid | 1 | 2011 | 24 | 0.370 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2011 | 39 | 0.360 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 694 | 0.240 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 767 | 0.230 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 2556 | 0.230 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 1191 | 0.220 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 1045 | 0.200 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 2368 | 0.170 |
Why?
|
| Lens Capsule, Crystalline | 2 | 2010 | 11 | 0.110 |
Why?
|
| Organoplatinum Compounds | 1 | 2011 | 95 | 0.090 |
Why?
|
| Capecitabine | 1 | 2011 | 92 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 96 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 106 | 0.080 |
Why?
|
| Deoxycytidine | 1 | 2011 | 212 | 0.080 |
Why?
|
| Quinazolines | 1 | 2011 | 214 | 0.080 |
Why?
|
| Cataract | 1 | 2010 | 87 | 0.080 |
Why?
|
| Fluorouracil | 1 | 2011 | 549 | 0.080 |
Why?
|
| Membranes | 1 | 2008 | 37 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2011 | 900 | 0.070 |
Why?
|
| Lens, Crystalline | 1 | 2008 | 69 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2008 | 129 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1939 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1310 | 0.060 |
Why?
|
| Aged | 3 | 2013 | 19943 | 0.060 |
Why?
|
| Middle Aged | 3 | 2013 | 27030 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 1576 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2011 | 3508 | 0.040 |
Why?
|
| Female | 3 | 2013 | 47893 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 283 | 0.040 |
Why?
|
| Neoplasms | 1 | 2013 | 3117 | 0.040 |
Why?
|
| Actins | 2 | 2010 | 470 | 0.030 |
Why?
|
| Humans | 3 | 2013 | 92337 | 0.030 |
Why?
|
| Gossypol | 1 | 2013 | 5 | 0.030 |
Why?
|
| Rats | 2 | 2010 | 4067 | 0.030 |
Why?
|
| Etoposide | 1 | 2013 | 206 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2013 | 268 | 0.020 |
Why?
|
| Male | 2 | 2013 | 43925 | 0.020 |
Why?
|
| Cisplatin | 1 | 2013 | 602 | 0.020 |
Why?
|
| Sutures | 1 | 2010 | 60 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 375 | 0.020 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2008 | 5 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2008 | 34 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 323 | 0.020 |
Why?
|
| Cadherins | 1 | 2008 | 165 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 212 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 430 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 1235 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2008 | 680 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1786 | 0.010 |
Why?
|
| Animals | 2 | 2010 | 28003 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 27532 | 0.010 |
Why?
|